COMPANY
Apreo Health
Timeline
- Trial start Not phased (device or behavioral study): Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3 source ↗
- Trial start Not phased (device or behavioral study): Study to Assess Safety, Feasibility, and Preliminary Efficacy of the Apreo Implant for Severe Emphysema source ↗
- Trial start Not phased (device or behavioral study): First in Human Study to Assess an Implant to Treat Severe Emphysema source ↗
Upcoming milestones
- Sep 30, 2027 (ESTIMATED) · Not phased · Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3 · NCT06891755
Clinical trials (lead sponsor) 3
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT06891755 | Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3 | Not phased (device or behavioral study) | Recruiting | Jul 15, 2025 | Sep 30, 2027 (estimated) |
| NCT05854550 | First in Human Study to Assess an Implant to Treat Severe Emphysema | Not phased (device or behavioral study) | Completed | May 5, 2023 | Oct 8, 2024 (actual) |
| NCT05949645 | Study to Assess Safety, Feasibility, and Preliminary Efficacy of the Apreo Implant for Severe Emphysema | Not phased (device or behavioral study) | Active, not recruiting | Aug 15, 2023 | Oct 8, 2024 (actual) |